Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Status of research on gender differences

M J Berg1

  • 1College of Pharmacy, University of Iowa in Iowa City, USA.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|January 1, 1997
PubMed
Summary

Gender bias in clinical trials is decreasing. Understanding pharmacokinetic differences in women is crucial, especially during pregnancy and across the life cycle, as highlighted by the Women's Health Initiative.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transduction of E13 murine neural precursor cells by non-immunogenic recombinant adeno-associated viruses induces major changes in neuronal phenotype.

Neuroscience·2012
Same author

Prodynorphin processing by rat CNS fractions and purified enzymes: Formation of Dynorphin A 1-8 by sulfhydryl-activated carboxypeptidase and peptidyl dipeptidase.

Neurochemistry international·2010
Same author

Separate metabolic pathways for Leu-enkephalin and Met-enkephalin-Arg(6)-Phe(7) degradation by rat striatal synaptosomal membranes.

Neurochemistry international·2010
Same author

Evidence for conversion of N-Tyr-MIF-1 into MIF-1 by a specific brain aminopeptidase.

Neurochemistry international·2010
Same author

Generic substitution in the treatment of epilepsy: case evidence of breakthrough seizures.

Neurology·2008
Same author

Opposite effects of lithium on proximal and distal caspases of immature and mature primary neurons correlate with earlier paradoxical actions on viability.

Neurochemical research·2002

Area of Science:

  • Pharmacology and Clinical Trials
  • Women's Health Research

Background:

  • Historical underrepresentation of women in clinical trials persists.
  • Pharmacokinetics (drug absorption, distribution, metabolism, elimination) can differ between genders.
  • Physiological changes throughout a woman's life cycle, including pregnancy, impact drug behavior.

Purpose of the Study:

  • To examine gender differences in drug pharmacokinetics.
  • To highlight the importance of including women in clinical research.
  • To inform the ongoing Women's Health Initiative.

Main Methods:

  • Review of pharmacokinetic principles and gender-specific variations.
  • Analysis of existing literature on drug disposition in women.
  • Consideration of data from large-scale women's health studies.

Main Results:

  • Pharmacokinetic parameters show significant gender-based variability.
  • Pregnancy and other life stages markedly alter drug pharmacokinetics.
  • The Women's Health Initiative provides a framework for studying these differences.

Conclusions:

  • Addressing gender bias in clinical trials is essential for accurate drug efficacy and safety.
  • Further research into sex-specific pharmacokinetics is warranted.
  • Integrating findings into women's health strategies improves medical care.

Related Experiment Videos